Your browser doesn't support javascript.
loading
Dynamic Regulatory Assessment: Unpacking the Process Reveals Readiness to Pilot for Europe-An EFPIA View.
Todd, Iain; Faust, Ruediger; Herrero-Martinez, Esteban; Hussain, Nasir; Kawinski, Adam; Lennard, Andrew; Roux, Nadege Le; Macdonald, Judith; Mayer, Mark; Palacios, Rodrigo; Dangy-Caye, Agnès.
Affiliation
  • Todd I; GSK, Brentford, United Kingdom. Electronic address: iain.t.todd@gsk.com.
  • Faust R; UCB Biosciences GmbH, Monheim am Rhein, Germany.
  • Herrero-Martinez E; AbbVie Ltd, Maidenhead, United Kingdom.
  • Hussain N; Gilead Sciences, Uxbridge, United Kingdom.
  • Kawinski A; Boehringer Ingelheim International GmbH, Biberach, Germany.
  • Lennard A; Amgen Ltd, Uxbridge, United Kingdom.
  • Roux NL; Celgene, a Bristol Myers Squibb company, Boudry, Switzerland.
  • Macdonald J; Pfizer Research and Development Ltd, Tadworth, United Kingdom.
  • Mayer M; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Palacios R; F. Hoffmann-La Roche, Basel, Switzerland.
  • Dangy-Caye A; Global Regulatory Affairs, Sanofi R&D, Chilly Mazarin, France. Electronic address: agnes.dangy-caye@sanofi.com.
Clin Ther ; 45(11): 1142-1147, 2023 11.
Article in En | MEDLINE | ID: mdl-37704457

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug and Narcotic Control / Drug Industry Limits: Humans Country/Region as subject: Europa Language: En Journal: Clin Ther Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug and Narcotic Control / Drug Industry Limits: Humans Country/Region as subject: Europa Language: En Journal: Clin Ther Year: 2023 Document type: Article